As the US Food and Drug Administration's independent advisers prepare to discuss Thursday the full approval of Pfizer's Covid-19 antiviral, Paxlovid, agency experts said this week that clinical trial data shows that it is safe and effective for treatment of mild to moderate illness in high-risk adults. ...

Veru has decided to proceed with a late-stage study of a COVID pill despite a health regulator declining to authorize it. The oral drug treats high-risk patients hospitalized with COVID-19. ...